In the bureaucratic, slow moving world of healthcare, technology is beginning to dictate the direction of medicine.
From precision initiatives set to customize every aspect of our health, to on-demand doctors, tech and medicine go together like penicillin and mouldy bread.
Instead of a paternalistic system where doctors tell people what to do, healthtech could help increase patients’ knowledge and power, changing the relationship into something considerably more dynamic and collaborative.
VC’s stand behind this sentiment, which explains the steady flow of capital helping establish the foundations of an industry that could help to save many lives.
It has increased year on year, and in 2015 to date $3.4 billion has been invested across 374 healthtech startup investments worldwide.
Coming out on top is Denali Therapeutics, the San Francisco based business taking a novel approach in the hunt to cure neurodegenerative diseases such as Alzheimer and Parkinson’s.
And with its chair having given up a board seat at Pfizer to join, the firm that’s just raised $217 million are entering unchartered territory.
Coming second in the top healthtech startup investments of 2015 is Nanthealth, a healthtech company owned by the richest doctor in the history of the world.
Patrick Soon-Shiong, estimated by Forbes to be worth $10.1 billion is spearheading a powerful genome-sequencing project with a focus on a more personalized treatment approach to cancer patients.
And what’s more, it works fast.
Within 47 seconds the database will decide which drugs should be used for treatment based on a patient’s genome.
Once sequencing is complete, patients are sent home to carry out their course of medicine. Couple this with doctors’ ability to monitor patients in real time – and we could be set to see a bold step toward eliminating cancer once and for all.
For more of the top healthtech startup investments, see the above infographic.